SCHEMBL19031877

SCHEMBL19031877

CCC(C(=O)O)(c1ccccc1)c1cncnc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 6/20 0.43
▸ CHRM2 P08172 2/20 0.42
▸ CHRM1 P11229 2/20 0.42
▸ CHRM3 P20309 2/20 0.42
▸ OPRM1 P35372 4/20 0.41
▸ DRD3 P35462 3/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ GRIN2D O15399 2/20 0.38
▸ GRIN1 Q05586 2/20 0.38
▸ GRIN2A Q12879 2/20 0.38
▸ GRIN2B Q13224 2/20 0.38
▸ GRIN2C Q14957 2/20 0.38
▸ DRD4 P21917 2/20 0.38
▸ CACNA1F O60840 1/20 0.38
▸ ABCB1 P08183 1/20 0.38
▸ CYP2B6 P20813 1/20 0.38
▸ OPRD1 P41143 1/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ CACNA1D Q01668 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL396913 0.86 CHRM2 (0.51) CHRM2CHRM1CHRM3OPRM1DRD3
SCHEMBL28929695 0.83 CHRM2 (0.53) CYP19A1CHRM2CHRM1CHRM3OPRM1
Phosphonic Acid SCHEMBL29035527 0.79 CHRM2 (0.46) CHRM2CHRM1CHRM3OPRM1DRD3
SCHEMBL27965739 0.77 ESR1 (0.52) CHRM2CHRM1CHRM3OPRM1DRD3
SCHEMBL3391343 0.76 OPRM1 (0.47) CHRM2CHRM1CHRM3OPRM1DRD3
SCHEMBL10452446 0.76 KCNN4 (0.51) CHRM2CHRM1CHRM3OPRM1DRD3
SCHEMBL14810250 0.75 CHRM2 (0.39) CHRM2CHRM1CHRM3OPRM1DRD3
SCHEMBL11752498 0.74 CHRM2 (0.51) CHRM2CHRM1CHRM3OPRM1DRD3
SCHEMBL19031888 0.74 HDAC3 (0.47) CYP19A1CYP2C19HIF1ABCAT2CYP1A2
SCHEMBL2202827 0.73 CHRM3 (0.47) CHRM2CHRM1CHRM3OPRM1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3394067-A1 4-AMINO-2-(1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)-6-OXO-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THE RESPECTIVE (1H-INDAZOL-3-YL) DERIVATIVES AS CGMP MODULATORS FOR TREATING CARDIOVASCULAR DISEASES Merck Sharp & Dohme Corp. (US) 2018-10-31 — — EP disclosed
WO-2017112617-A1 4-AMINO-2-(1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)-6-OXO-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THE RESPECTIVE (1H-INDAZOL-3-YL) DERIVATIVES AS CGMP MODULATORS FOR TREATING CARDIOVASCULAR DISEASES MERCK SHARP & DOHME CORP. (US) 2017-06-29 — — WO disclosed
Send feedback